About Ardea Biosciences (NASDAQ:RDEA)
Ardea Biosciences, Inc. (Ardea) is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases. The Company's product portfolio includes Lesinurad (RDEA594), RDEA3170 and BAY 86-9766 (RDEA119). Lesinurad (RDEA594) is an inhibitor of the URAT1 kidney transporter for the treatment of gout. RDEA3170 is a URAT1 kidney transporter inhibitors for the treatment of gout. BAY 86-9766 (RDEA119) is a MEK inhibitor for the treatment of cancer. On June 19, 2012, AstraZeneca PLC acquired the Company.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Ardea Biosciences (NASDAQ:RDEA) Frequently Asked Questions
What is Ardea Biosciences' stock symbol?
Ardea Biosciences trades on the NASDAQ under the ticker symbol "RDEA."
Who are some of Ardea Biosciences' key competitors?
Some companies that are related to Ardea Biosciences include Johnson & Johnson (JNJ), Novartis (NVS), UnitedHealth Group (UNH), Pfizer (PFE), Roche (ROG), AbbVie (ABBV), Merck & Co., Inc. (MRK), Amgen (AMGN), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Abbott Laboratories (ABT), GlaxoSmithKline (GSK), AstraZeneca (AZN), Sanofi (SAN), Bayer (BAYN), CSL (CSL), Celgene (CELG) and Danaher (DHR).
How do I buy Ardea Biosciences stock?
Shares of Ardea Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Ardea Biosciences?
Ardea Biosciences' mailing address is 4939 Directors Pl, SAN DIEGO, CA 92121-3829, United States. The biotechnology company can be reached via phone at +1-858-6526500.
MarketBeat Community Rating for Ardea Biosciences (RDEA)MarketBeat's community ratings are surveys of what our community members think about Ardea Biosciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Ardea Biosciences (NASDAQ:RDEA) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Ardea Biosciences (NASDAQ:RDEA) Earnings History and Estimates Chart
Ardea Biosciences (NASDAQ RDEA) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Ardea Biosciences (NASDAQ:RDEA) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Ardea Biosciences (NASDAQ:RDEA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Ardea Biosciences (NASDAQ RDEA)
No insider trades for this company have been tracked by MarketBeat.com
Ardea Biosciences (NASDAQ RDEA) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Ardea Biosciences (NASDAQ:RDEA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Ardea Biosciences (NASDAQ:RDEA) Income Statement, Balance Sheet and Cash Flow Statement
Ardea Biosciences (NASDAQ RDEA) Stock Chart for Friday, February, 23, 2018